EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Results of patch testing propolis in the European baseline series: A 4‐year retrospective study

Gizem Kocabas, Norbertus A Ipenburg iD, Anton de Groot iD, Thomas Rustemeyer iD

Contact Dermatitis · 2024

DOI: 10.1111/cod.14678 ↗

At a glance

Journal article in Contact Dermatitis, 2024. Written by Gizem Kocabas and 3 co-authors. Institution: Amsterdam University Medical Centers, Amsterdam, The Netherlands. Major MEDLINE topics: Propolis, Patch Tests, Dermatitis, Allergic Contact. Cited 16 times so far (Crossref); 10 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Propolis was added to the European baseline series (EBS) in 2019.

Objectives

To investigate the frequency and relevance of positive patch tests to propolis in the EBS and to study co‐reactivities. Patients and Methods Retrospective study in patients patch tested between June 2019 and November 2023 in a university hospital in Amsterdam, The Netherlands.

Results

Of 3134 consecutive patients, 299 (9.5%) had a positive reaction to propolis 10% pet. Only nine reactions (3%) were judged to be clinically relevant. There were significant co‐reactivities to Myroxylon pereirae resin (balsam of Peru), colophonium, fragrance mixes 1 and 2, and to limonene and linalool hydroperoxides. A steep increase in rates of positive reactions to propolis was observed from 2020 to 2023. This was highly likely the result of the replacement of Chinese propolis with Brazilian propolis by the manufacturer.

Conclusions

Positive patch tests for propolis are very frequent in Amsterdam, but only a few of these reactions are relevant. Most are probably (pseudo‐)cross‐reactions in patients with fragrance allergies. Propolis in the EBS has very limited value for dermatologists and patients in The Netherlands. Changes in patch test materials should be provided to all users to avoid misinterpretation of patch test results.

Subjects

MeSH terms (MEDLINE)

PropolisPatch TestsDermatitis, Allergic ContactHumansRetrospective StudiesFemaleMaleMiddle AgedAdultNetherlandsPerfumeCross ReactionsBalsamsAgedMyroxylonAcyclic MonoterpenesAllergens

Author keywords

Brazilian propolisChinese propolisMyroxylon pereirae resinallergic contact dermatitisbalsam of Perubee gluecolophoniumcontact allergycosmeticscross‐reactionsfragrance mix 1fragrance mix 2propolispseudo‐cross‐reactions

Substances

PropolisPerfumeBalsamsAcyclic MonoterpenesAllergens

Authors and institutions

  • Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

ORCID profiles: Norbertus A Ipenburg, Anton de Groot, Thomas Rustemeyer

Cite

APA

Kocabas, G., Ipenburg, N. A., de Groot, A., & Rustemeyer, T. (2024). Results of patch testing propolis in the European baseline series: A 4‐year retrospective study. Contact Dermatitis. https://doi.org/10.1111/cod.14678

Vancouver

Kocabas G, Ipenburg NA, de Groot A, Rustemeyer T. Results of patch testing propolis in the European baseline series: A 4‐year retrospective study. Contact Dermatitis. 2024. doi:10.1111/cod.14678

BibTeX
@article{Kocabas2024,
  author = {Kocabas, Gizem and Ipenburg, Norbertus A and de Groot, Anton and Rustemeyer, Thomas},
  title = {Results of patch testing propolis in the European baseline series: A 4‐year retrospective study},
  journal = {Contact Dermatitis},
  year = {2024},
  doi = {10.1111/cod.14678}
}
Start for free →